According to Data Bridge Market Research new Market report, global whole exome sequencing market will account to an estimated USD 883.90 million in 2018 growing at a CAGR of 21.50% during the forecast period of 2019 to 2026.
Access Full Report at https://databridgemarketresearch.com/reports/global-whole-exome-sequencing-market/
Whole Exome Sequencing which is also known as exome sequencing is a technique which is used for sequencing all protein- coding of genes in a genome also known exome. It can identify thee genetics which are responsible for diseases like Miller Syndrome and Alzheimer disease In this technique all the exomes and protein-coding genes in a genome are sequenced by selecting that subset of DNA that encodes proteins or exons and sequencing them using high-throughput DNA sequencing methods.
Global Whole Exome Sequencing Market is segmented on the basis of metal form, production method, compaction technique, metal powder and geography.
By Products And Services (Systems, Kits, Services), Technology (Sequencing By Synthesis , Ion Semiconductor Sequencing, Other Technologies), Applications (Diagnostics, Drug Discovery and Development, Personalized Medicine, Agriculture and Animal Research, Others ), End-User (Research Centers And Academic And Government Institutions, Hospitals And Clinics, Pharmaceutical and Biotechnology Companies, Other End Users), Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa)
FACTORS DRIVING GROWTH IN WHOLE EXOME SEQUENCING MARKET
Increasing Geriatric Population
It is expected that the world’s population aged 60 years will be 2 billion by 2050, which is 900 million in 2015.
Japan has the 27% of the population of 65 years of age or older which is the highest in 2015-16. Then is Italy with 23% and then Portugal with 22%. Then other countries like Germany, Bulgaria and Finland with 21%, Greece, Sweden, Latvia and Croatia with 20% respectively.
Few of the major competitors currently working in the whole exome sequencing market are llumina, Inc., Life Technologies (acquired by Thermo Fisher Scientific, Inc.), Roche NimbleGen, Inc., Agilent Technologies, BGI (Beijing Genomics Institute, China), Eurofins Genomics, Inc., Sengenics., GENEWIZ, Inc., Knome, Inc., Macrogen, Inc., and Ambry Genetics
Browse Related Reports:
Global Next Generation Sequencing (NGS) Market,By Product (Instruments (Hiseq series, Miseq series, ION Torrent, SOLiD, Pacbio Rs II and Sequel system), Consumables (Sample preparation consumables, Other), Services (Sequencing services, Data management services), by Application (Diagnostics, Drug Discovery , Biomarker Discovery , Precision Medicine , Agriculture & Animal Research), by End-user (Hospitals & Clinics, Research Centers and Academic & Government Institutes, and Pharmaceutical & Biotechnology Companies), by Geography (North America, Europe, Asia-Pacific, Europe, South America, Middle East and Africa) – Industry Trends and Forecast to 2024
Global In Vitro Diagnostics/IVD Market By Technology (Immunochemistry/Immunoassays, Clinical Chemistry, Molecular Diagnostics, Clinical Microbiology, Hematology, Coagulation and Hemostasis), By Product & Service (Reagents & Kits, Instruments, Data Management Software, Services), By Application (Diabetes, Infectious Diseases, Oncology/Cancer, Cardiology, Nephrology, Autoimmune Diseases, Drug Testing or Pharmacogenomics, HIV/AIDS), By End-User (Hospitals, Laboratories, Point-Of-Care Testing, Patient Self-Testing, Academic Institutes), By Geography – Industry Trends and Forecast to 2024.
Global Whole Exome Sequencing Market – Industry Trends and Forecast to 2028